Abstract
Objective:Systemic lupus erythematosus (SLE) is a complex multi-organ disease, characterised by relapses and remissions. Designing a high-quality randomised controlled trial poses many challenges. We have developed evidenced-based recommendations for points...
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have